Vikas Sinha
CIK 1337845 · Chief Financial Officer · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$27.39M
Companies
3
Total Filings
128
Lifetime Open-Market Net
-$4.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | Chief Financial Officer | 619,856 | $44.18 | $27.39M | -$1.23M | 5 | 2026-04-20 |
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$3.18M | 12 | 2025-10-08 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | See Remarks | 774,118 | $9.81 | $7.59M | -$246.5K | 40 | 2025-02-24 |
Recent Filings · Page 13 of 13
128 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-09-23 | — | Sell (S) | −2,065 | -$85.4K | |
| 2008-08-05 | — | Mixed | — | -$647.7K | |
| 2008-07-11 | — | Sell (S) | −159 | -$12.0K | |
| 2008-03-26 | — | Sell (S) | −1,025 | -$59.7K | |
| 2008-01-11 | — | Mixed | +3,789 | -$49.1K | |
| 2007-09-25 | — | Sell (S) | −4,162 | -$263.0K | |
| 2007-07-12 | — | Grant (A) | — | $0 | |
| 2007-01-17 | — | Grant (A) | +5,000 | $0 |
Showing 121–128 of 128
Prev
Page 13 of 13
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.